Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 12 studies | 23% ± 8% | |
adipocyte | 4 studies | 35% ± 24% | |
extravillous trophoblast | 3 studies | 47% ± 13% | |
mesothelial cell | 3 studies | 27% ± 4% |
Insufficient scRNA-seq data for expression of VGLL3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 8279.44 | 577 / 578 | 87% | 5.64 | 1002 / 1155 |
breast | 99% | 4025.37 | 454 / 459 | 87% | 4.60 | 971 / 1118 |
bladder | 100% | 2660.81 | 21 / 21 | 79% | 13.21 | 400 / 504 |
prostate | 95% | 3211.88 | 233 / 245 | 82% | 24.62 | 413 / 502 |
ovary | 93% | 2627.29 | 168 / 180 | 46% | 1.46 | 196 / 430 |
uterus | 95% | 3618.05 | 161 / 170 | 44% | 5.48 | 202 / 459 |
esophagus | 66% | 1638.65 | 950 / 1445 | 70% | 3.73 | 128 / 183 |
skin | 84% | 10314.88 | 1517 / 1809 | 43% | 1.36 | 203 / 472 |
intestine | 73% | 2335.81 | 703 / 966 | 46% | 2.12 | 240 / 527 |
pancreas | 15% | 198.83 | 50 / 328 | 92% | 7.81 | 164 / 178 |
thymus | 73% | 1538.06 | 478 / 653 | 32% | 1.21 | 193 / 605 |
stomach | 38% | 998.14 | 138 / 359 | 63% | 2.72 | 181 / 286 |
adipose | 100% | 7503.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.85 | 1 / 1 |
blood vessel | 100% | 5792.47 | 1329 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 53% | 1.18 | 24 / 45 |
heart | 52% | 981.48 | 452 / 861 | 0% | 0 | 0 / 0 |
kidney | 7% | 87.69 | 6 / 89 | 35% | 1.27 | 317 / 901 |
adrenal gland | 14% | 188.53 | 35 / 258 | 20% | 0.50 | 45 / 230 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.37 | 7 / 29 |
liver | 1% | 30.04 | 3 / 226 | 15% | 0.65 | 60 / 406 |
muscle | 13% | 190.61 | 104 / 803 | 0% | 0 | 0 / 0 |
spleen | 7% | 89.98 | 16 / 241 | 0% | 0 | 0 / 0 |
brain | 1% | 12.94 | 19 / 2642 | 5% | 0.16 | 34 / 705 |
peripheral blood | 0% | 1.39 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
Gene name | VGLL3 |
Protein name | Vestigial like family member 3 Transcription cofactor vestigial-like protein 3 (Vgl-3) |
Synonyms | |
Description | FUNCTION: May act as a specific coactivator for the mammalian TEFs. . FUNCTION: May act as a specific coactivator for the mammalian TEFs. . |
Accessions | ENST00000398399.7 [A8MV65-1] ENST00000383698.3 [A8MV65-2] ENST00000637106.1 A8MV65 H7C571 A0A1B0GTF5 ENST00000494229.1 |